Induction of Protective Immunity Against Cryptococcosis

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, is an encapsulated fungal pathogen that can cause life-threatening infections of the central nervous system in immune compromised individuals resulting in high morbidity and mortality. Consequently, several studies have endeavored to understand those mechanisms that mediate resistance and susceptibility to Cryptococcus infection. In this review, we will examine the contributions of various components of the innate and adaptive immune response toward protection against cryptococcosis. We will focus our discussion on studies presented at the 8th International Conference on Cryptococcus and Cryptococcosis (ICCC). Remarkable progress has been made toward our understanding of host immunity and susceptibility to cryptococcal infection and the potential for vaccine development.     

New tricks for an old-favorite model

A report of the 24th International Conference on Yeast Genetics and Molecular Biology, Manchester, UK, 19-24 July 2009.The international yeast meetings are highly interactive conferences attracting scientists from diverse disciplines of fungal research. The 24th yeast meeting held in the University of Manchester presented recent advances ranging from basic cell biology to the use of yeast for industrial purposes and translational research. Here, I summarize a few highlights related to systems and synthetic biology, yeasts as model organisms in gene expression, aging and human disease studies and the use of yeast cells as factories.     

Oxidative Mechanisms in Neurodegenerative Disorders. Proceedings from a satellite symposium, Guilin, China, 7-11 February 2004

This special issue of Molecular Neurobiology presents a series of mini-reviews resulting from an ISN satellite symposium entitled Oxidative Mechanisms in Neurodegenerative Disorders Held at the Guilin Park Hotel, Guilin, China on February 7-11, 2004. The timely topics in this symposium were contributed by more than 20 internationally acclaimed scientists and attended by more than 100 participants interested in this subject matter. This satellite symposium was also part of the 6th Biennial Asian-Pacific Society for Neurochemistry (APSN) meeting held in Hong Kong, China. Organizers included Dr. Piu Chan (Capital University of Medical Sciences and Beijing Institute of Geriatrics) Dr. Albert Y. Sun and Dr. Grace Y. Sun (University of Missouri, Columbia, MO). The satellite meeting was hosted by Xuanwu Hospital of Capital University of Medical Sciences and Guilin Medical College, and was generously supported by the following: the International Society of Neurochemistry (ISN), National Institutes of Health (USA) (1 R13 NS047414), the Geriatric Research, Education and Clinical Center (GRECC) VA Medical Center, Minneapolis, MN, USA, The Chinese Society of Neuroscience, Chinese Medical Association, Chinese Journal of Neurology, Shanghai Roche Pharmaceuticals Ltd., and Beijing QuiXave United Technology Ltd. Corporation.     

A Chronological History of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an Invaluable Forum for Growth of the Cryptococcal Research Field and Clinical Practice

Cryptococcologists meet every 3 years to present their new research data and discuss the current state of cryptococcosis therapy at the International Conference on Cryptococcus and Cryptococcosis (ICCC). The ICCC has served as a unique forum where mycologists could interact and share their research data in a setting exclusively devoted to the study of Cryptococcus and cryptococcosis. This article presents an historical perspective on the ICCC meetings, beginning with the first ICCC that was held in Jerusalem, Israel in 1989. Subsequent ICCC meetings have grown, in terms of attendance and submitted abstracts. The history of the ICCC serves as a testimony to the remarkable progress that has been made in our basic understanding of the molecular biology, biochemistry, ecology, and taxonomy of Cryptococcus as well as the epidemiology, immunology, clinical manifestations, and treatment for cryptococcosis.     

第八届世界食用菌生物学及产品大会通知（英文）

<正>About the Conference8th International Conference on Mushroom Biology and Mushroom Products(ICMBMP8)is being organized to bring together scientists and other professionals with an interest in mushrooms and mushroom products,including those associated with economic,environmental and engineering issues.This will also be an opportunity to     

Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010

The 2010 7th International Melanoma Congress sponsored by the Society for Melanoma Research and held in Sydney, Australia, was held together with the International Melanoma and Skin Cancer Centers group and the International Melanoma Pathology Study Group. As a consequence, there were over 900 registrants that included a wide range of clinicians (surgeons, medical oncologists, dermatologists) specialising in the management of melanoma as well as scientists and students carrying out laboratory-based research in melanoma. There was a general consensus that this grouping of clinicians, pathologists and scientists was mutually advantageous and plans are afoot to continue this grouping in future meetings. The meeting was dominated by the advances being made in treatment of melanoma with selective BRAF inhibitors but interest in epithelial mesenchymal transition and phenotypic changes in melanoma was apparent in many of the talks. The authors have attempted to capture many of the new developments in melanoma research but apologize to those speakers and poster presenters who had equally important findings not captured in these summaries.     

Meeting report: Symbiosis in Barcelona

The European Congress on Biotechnology brought together the top European and International scientists, biotechnologists, innovators and key biotech policy and decision makers in an unprecedented international meeting. The Congress was established in 1978 by and remains the main activity of the European Federation of Biotechnology (EFB). Taking place in Barcelona, September 16–19, 2007, the ECB 13 attracted over 1500 leading scientists and other senior participants, over 500 posters and more than a hundred exhibitors, from over 50 countries across Europe and beyond. From over a 150 presentations in 5 and more parallel sessions, only a small fraction can be highlighted in the scope of this short meeting report.     

The way of the germline, its developmental cycle and epigenetic network

The long-awaited second edition of the International Symposium on "Epigenome Network, Development and Reprogramming of Germ Cells" hosted by Hiroyuki Sasaki took place at the Kyushu University School of Medicine, in Fukuoka, Japan from 22 to 24 November 2010. This meeting brought together again the crème de la crème of the Japanese research community investigating germline development, reprogramming and genetic networks as well as eminent international scientists. Novel trend concepts including the "reprogramming expressway", "canalization", "licensing", "epigenetic barrier", "flex points" and "hydroxymethylation" were introduced and discussed in the context of development, reprogramming and pluripotency.     

Meeting report: fourth international congress of the Society for Melanoma Research

The 4th international melanoma congress of the Society for Melanoma Research (SMR), organized by Marianne Berwick (University of New Mexico), Paul Chapman (Memorial Sloan-Kettering Cancer Center), Rene Gonzalez (University of Colorado) and Ze'ev Ronai (Burnham Institute), was held at the Marriott Hotel in downtown New York on November 2007. The congress was attended by a record high number of attendees (over 500 delegates) who joined to discuss recent advances in melanoma biology and therapy. About 40% of the participants arrived from 39 countries, a testament to the high impact of this annual gathering on the international melanoma community. Over 120 of the participants were students or postdoctoral fellows, representing a most impressive fraction of young scientists engaged in melanoma research. The meeting consisted of more than 50 plenary and minisymposia presentations, stimulating the exchange of unpublished data and novel ideas, and helping to forge new collaborations that are anticipated to facilitate significant advances in basic, translational and clinical melanoma research. Another major focus of this meeting was over 160 posters, which were heavily attended and provided an effective forum for extensive informal discussions. This report will highlight the major scientific themes and advances of this most successful meeting, and provide a useful perspective on the current state of melanoma research, as well as where the field should be heading.     

The 6(th) East Midlands Proteomics Workshop supported by the BSPR and BMSS 14 November 2007, Nottingham, UK

Now in its 6(th) year, the East Midlands Proteomics workshop held in November 2007 brought together over 200 scientists with a common interest in proteomic techniques and their application to complex biological and biomedical problems. For the first time, this meeting was jointly supported by the British Society for Proteome Research (BSPR) and British Mass Spectrometry Society (BMSS).     

JDRC 8: History,Neurobiology and Imaging

The 8th Japanese Drosophila Research Conference (JDRC8) took place in the Awaji island in Kansai Area (July2-4, 2007), attracting more than 300 participants including 66 non-Japanese-speaking scientists. The meeting was held for the first time solely in English. In this report, we summarize the part of developmental neurobiology, neuroscience, behaviour and imaging.     

IX international conference on Salt Lake research: Research opportunities and management challenges

The 9th International Conference on Salt Lake Research was held 26–30 September 2005 in Western Australia at the Curtin University of Technology, Perth, Australia. One hundred scientists from 10 countries presented research on a diverse array of topics highlighting research findings and opportunities, and management challenges associated with inland saline waters. Major emergent themes of the conference included modeling of ecosystem processes, microbial communities, and features of Western Australian inland saline environments, including current threats, conservation and management.     

Keystone Symposium on Antibodies as Drugs: March 27–April 1, 2009, Whistler,BC CA

The symposium on Antibodies as Drugs, organized by Keystone Symposia and chaired by J. Marks, (University of California Los Angeles, USA), E.S. Ward (University of Texas Southwestern Medical Center, USA) and L. Weiner (Georgetown University Medical Center, USA), was held in Whistler, British Columbia. This Canadian Rockies village, which will host the 2010 Olympic Games, served as an enchanting backdrop to the meeting. The more than 350 speakers and attendees included scientists from major pharmaceutical firms, e.g., Abbott, MedImmune/Astra Zeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi-Aventis, Schering, GlaxoSmithKline, Eli Lilly, Hoffmann LaRoche, Novartis, Wyeth, and biotechnology companies, e.g., Ablynx, Medarex, Morphosys, GenMab, Amgen, Genentech, ImmunoGen, Agensys, Domantis, Biogen Idec, Centocor, LFB, Micromet, PDL Biopharma, Borean Pharma, Dyax Corp., Symphogen and Syntonix. Academic research groups at Imperial College London, University of Oxford, ETH Zürich, Scripps, Institute Cochin, Karolinska Institute, Utrecht University, Harvard Medical School, Massachusetts Institute of Technology, Baylor College, Paul Ehrlich Institute, University of California San Francisco, University of California San Diego, University of Nantes, University of Tours and Ludwig Institute were also represented, as were regulatory authorities, including the US Food and Drug Administration, National Institutes of Health and the Public Health Agency of Canada). The meeting was very interactive and included thoughtful exchanges during the different sessions and networking events.     

Keystone Symposium on Antibodies as Drugs

The symposium on Antibodies as Drugs, organized by Keystone Symposia and chaired by J. Marks, (University of California Los Angeles, USA), E.S. Ward (University of Texas Southwestern Medical Center, USA) and L. Weiner (Georgetown University Medical Center, USA), was held in Whistler, British Columbia. This Canadian Rockies village, which will host the 2010 Olympic Games, served as an enchanting backdrop to the meeting. The >350 speakers and attendees included scientists from major pharmaceutical firms, e.g., Abbott, MedImmune/Astra Zeneca, Bristol-Myers Squibb, Merck & Co, Pfizer, Sanofi-Aventis, Schering, GlaxoSmithKline, Eli Lilly, Hoffmann LaRoche, Novartis, Wyeth, and biotechnology companies, e.g., Ablynx, Medarex, Morphosys, GenMab, Amgen, Genentech, ImmunoGen, Agensys, Domantis, Biogen Idec, Centocor, LFB, Micromet, PDL Biopharma, Borean Pharma, Dyax Corp, Symphogen, Syntonix. Academic research groups at Imperial College London, University of Oxford, ETH Zürich, Scripps, Institute Cochin, Karolinska Institute, Utrecht University, Harvard Medical School, Massachusetts Institute of Technology, Baylor College, Paul Ehrlich Institute, University of California San Francisco, University of California San Diego, University of Nantes, University of Tours, and Ludwig Institute were also represented, as were regulatory authorities, including the US Food and Drug Administration, National Institutes of Health and the Public Health Agency of Canada). The meeting was very interactive, and included thoughtful exchanges during the different sessions and networking events.     

Barrels XXVIII take the Windy City by storm

The 28th annual Barrels meeting was held prior to the Society for Neuroscience meeting in October 2015 at the Northwestern University School of Law in Chicago, Illinois. The meeting brought together researchers focused on the rodent sensorimotor system. The meeting focused on modern techniques to decipher cortical circuits, social interactions among rodents, and decision-making. The meeting allowed investigators to share their work via short talks, poster presentations, and a data blitz.     

Barrels XXIII: Barrels by the shore

The 23rd annual Barrels meeting was held on the University of California, San Diego campus and highlighted the latest advances in the whisker-to-barrel pathway and beyond. The annual meeting brought together investigators from a dozen countries to present their data in posters and short talks. The meeting focused on several themes, first the barrel system was used as a model to study the consequences that result from alterations in the normal pattern(s) of development. A second session focused on what happens to whisker information once it leaves the layer IV barrel. A third session addressed issues of coding within the barrel system and a final session highlighted the latest advances in the engineering of transgenic mouse lines. The meeting highlighted the utility of the barrel system to study cortical circuitry in the normal and pathological state.     

Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1

Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 were among the first human retroviruses discovered in the early 1980's. The International Retrovirology Association is an organized effort that fostered the efforts of scientists and clinicians to form interdisciplinary groups to study this group of retroviruses and their related diseases. The Association promotes excellent science, patient education, and fosters the training of young scientists to promote "bench-to-bedside" research. The International Conference on Human Retrovirology: HTLV and Related Viruses sponsored by the Association supports clinicians and researchers in the exchange of research findings and stimulation of new research directions. This years conference will be held from June 22 to 25, in Montego Bay, Jamaica http://www.htlvconference.org.jm/. Since its inception in 1988, these conferences have provided a highly interactive forum for the global community of HTLV scientists. This is of particular importance as HTLV research enters its third decade and a new generation of scientists takes over this important work. Many of the scientists attending the meeting will be from developing countries where HTLV is endemic, consistent with the history of international collaborations that have characterized HTLV research. The International Conference on Human Retrovirology provides a unique opportunity for researchers of all disciplines interested in HTLV infections to meet their peers and to address the questions facing clinicians and scientists who study retroviruses, like HTLV.     

An illuminated view of molecular biology

A report on the 18th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB) and the 7th Special Interest Group meeting on Alternative Splicing, Boston, USA, 9-13 July 2010.     

The 8th International Conference of the Canadian Proteomics Initiative

The 8th International Conference of the Canadian Proteomics Initiative (CPI) was held at the Hilton Vancouver Metrotown Hotel in Burnaby, British Columbia from 3–5 May, 2008. With nearly 200 delegates, 32 speakers and more than 50 poster presentations, CPI 2008 covered a wide range of topics, including novel technologies, human and clinical proteomics, structural proteomics, bioinformatics, post-translational modifications, membrane and receptor proteomics, and plant and animal proteomics. This year’s conference was also highlighted by hands-on proteomics workshops at the University of Victoria Genome BC Proteomics Centre and the University of British Columbia, an inaugural meeting of the British Columbia Proteomics Network and focus meetings exploring opportunities for the formation of a nationwide association for Canadian proteomics and Genome British Columbia’s efforts towards large-scale global genomics and proteomics projects.